MILAN, ITALY – Amplifon, the global leader in hearing care retail, announced exceptionally strong financial results for the second quarter of 2026, marking its highest organic quarterly growth in two years and demonstrating improved profitability across its operations. The robust performance has led the company to confidently reaffirm its full-year outlook, even as it progresses with the ambitious integration planning for the recently announced acquisition of GN Hearing. This strategic move is poised to significantly expand Amplifon’s global footprint and technological capabilities, setting the stage for a new era of growth and innovation in the hearing care industry.
The first half of 2026 saw Amplifon record consolidated revenues of €1.186 billion (approximately $1.37 billion USD), reflecting a 1.3% increase at constant exchange rates compared to the same period in 2025. A significant driver of this growth was the impressive 3.5% organic growth, a testament to the company’s operational strength and market penetration across all its major geographic regions. This underlying organic expansion indicates a healthy demand for Amplifon’s products and services, transcending currency fluctuations and external market variables.
Profitability metrics also showcased a positive trajectory. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for the first half totaled €298 million (approximately $344 million USD), an increase of 3.6% from the first half of 2025. This uplift translated into an adjusted EBITDA margin improvement of 70 basis points, reaching 25.1%, underscoring the company’s enhanced operational efficiency and cost management strategies. Furthermore, adjusted net profit soared by 12.3% to €101.6 million (approximately $117 million USD) compared to the prior-year period, reflecting a strong bottom-line performance.
Accelerated Momentum in the Second Quarter
The true highlight of Amplifon’s recent financial disclosure was the accelerated performance observed in the second quarter of 2026. Consolidated revenues for Q2 reached €606 million (approximately $699 million USD), with organic growth hitting an impressive 4.7%. This figure represents the company’s strongest quarterly organic growth result in the past two years, signaling a significant turnaround and successful execution of strategic initiatives.
The positive momentum extended to profitability during the quarter. Adjusted EBITDA for Q2 increased by 6.1% to €156.2 million (approximately $180 million USD), with the adjusted EBITDA margin rising by an even more substantial 90 basis points to 25.8%. This margin expansion is particularly noteworthy as it demonstrates the scalability of Amplifon’s business model and its ability to translate revenue growth into improved earnings. Adjusted net profit for the second quarter also surged by 17.1% to €57.2 million (approximately $66 million USD), reinforcing the overall strength of the company’s financial health.
These exceptional results, as highlighted by the company, are a direct reflection of sustained growth across its diverse geographic markets and the positive impact of strategic initiatives and investments implemented throughout 2025. Among these, the "Fit4Growth" program stands out as a pivotal undertaking designed to enhance operational efficiency, streamline processes, and ultimately strengthen overall profitability.
The "Fit4Growth" Program: A Strategic Overhaul
Launched in 2025, Amplifon’s "Fit4Growth" program represents a comprehensive, multi-faceted strategy aimed at optimizing the company’s global operations and reinforcing its competitive edge. The program’s core philosophy centers on enhancing efficiency and focusing resources on the most promising avenues for sustainable growth. A significant component of this initiative involved a rigorous review and optimization of Amplifon’s extensive clinic network.
Under the "Fit4Growth" banner, Amplifon undertook decisive actions, including the closure of over 200 clinics globally that were identified as underperforming or strategically misaligned. This move, while potentially involving short-term costs and adjustments, is expected to yield long-term benefits by concentrating resources on high-potential locations and improving the overall productivity of the network. Furthermore, the company made strategic divestments, notably selling its UK business, and terminated a managed care agreement in the United States. These decisions were not taken lightly but reflect a disciplined approach to portfolio management, allowing Amplifon to shed non-core or less profitable assets and redirect focus towards regions and business models offering superior growth and margin potential.
Simultaneously, "Fit4Growth" emphasized continued investment in critical areas such as marketing, brand support, and clinic operations. This dual approach of streamlining operations while simultaneously bolstering brand presence and customer experience is crucial for maintaining market leadership. By investing in innovative marketing campaigns, enhancing customer engagement strategies, and upgrading clinic infrastructure, Amplifon aims to solidify its brand loyalty and attract new customers in an increasingly competitive landscape. The improved profitability seen in Q2 2026 serves as tangible evidence of the program’s early success, demonstrating that the strategic adjustments are indeed translating into stronger financial outcomes and a more robust competitive position. These actions suggest a proactive management approach, willing to make tough decisions in the short term for greater long-term value creation.
Global Market Performance Highlights
Amplifon’s strong performance was geographically diversified, underscoring the effectiveness of its global strategy and localized execution.
-
Europe, Middle East, and Africa (EMEA): The EMEA region reported robust organic growth during the second quarter, with Southern Europe emerging as a particularly strong performer. This region, a cornerstone of Amplifon’s business, saw its first-half adjusted EBITDA reach €236.5 million (approximately $273 million USD), with a commendable margin increase to 30.5%. The consistent performance in EMEA highlights the stability and maturity of these markets for Amplifon, coupled with targeted strategies that are yielding positive results. The focus on Southern Europe suggests successful localized marketing and service delivery in key national markets.
-
Americas: The Americas region demonstrated significant dynamism, achieving organic growth of 6.3% during the first half and a solid 6.0% in the second quarter. The company proudly noted that this performance surpassed the broader market average, indicating market share gains. In the United States, a critical market, robust private-pay activity successfully offset a contraction observed in the insurance segment. This resilience in the private-pay sector underscores the value proposition of Amplifon’s premium services and products for consumers willing to invest directly in their hearing health. First-half adjusted EBITDA for the Americas totaled €56.8 million (approximately $65 million USD), reflecting growth despite the mixed market conditions. The ability to navigate the complexities of the U.S. healthcare landscape, particularly the fluctuations in insurance-driven demand, showcases Amplifon’s adaptability.
-
Asia Pacific: The Asia Pacific region continued its upward trajectory with organic growth of 4.6% during the first half, primarily fueled by strong performance in key markets such as Australia and China. The region’s adjusted EBITDA increased by a healthy 9.4% to €47.8 million (approximately $55 million USD). This growth signifies the expanding potential of the APAC markets for hearing care, driven by increasing awareness, an aging demographic, and rising disposable incomes. Amplifon’s strategic investments in these emerging and growing markets appear to be paying off, positioning the company well for future expansion in a region with immense long-term potential.
Leadership’s Perspective and Future Confidence
Enrico Vita, Amplifon’s CEO, provided insightful commentary on the company’s stellar performance and future outlook. "In the second quarter, we delivered excellent results, achieving our highest organic growth in the past two years, outperforming the market across all geographies and significantly improving profitability," Vita stated. This declaration emphasizes not only the company’s internal achievements but also its strong competitive standing, indicating that Amplifon is not merely growing but is actively expanding its market share against competitors.
Vita further elaborated on the strategic underpinnings of this success: "These results confirm the effectiveness of the many initiatives and investments undertaken in 2025, which are now delivering tangible outcomes and further strengthening our competitive position." This directly links the improved financial metrics to the proactive measures like the "Fit4Growth" program, validating the strategic decisions made by the management team. The "tangible outcomes" refer to the improved margins and accelerated organic growth, which are critical indicators of successful strategic execution.
Looking ahead, Vita expressed strong confidence: "The very positive results achieved in the first half, together with the solid start to the third quarter, reinforce our confidence in the outlook for the full year 2026." This forward-looking statement suggests that the positive momentum from Q2 has continued into the current quarter, providing a robust foundation for achieving the full-year targets. This indication of sustained performance is crucial for investor confidence and market perception.
Finally, Vita also touched upon the transformative acquisition on the horizon: "We are also looking with great excitement at the opportunities that will arise from the integration with GN Hearing, a strategic step that will accelerate the Group’s growth, innovation and transformation, creating further value for all our stakeholders." This statement frames the GN Hearing acquisition not just as an expansion, but as a catalyst for accelerated growth, innovation, and a fundamental transformation of the Amplifon Group, promising enhanced value for customers, employees, and shareholders alike.
2026 Outlook and the Transformative GN Hearing Integration
Building on its strong first-half performance and the CEO’s confident remarks, Amplifon has unequivocally reaffirmed its previously announced expectations for the full year 2026. The company continues to project organic growth above 3% for the year, a target supported by the impressive 4.7% organic growth achieved in Q2. Furthermore, Amplifon anticipates an improvement in its adjusted EBITDA margin of approximately 100 basis points. This margin expansion is expected to stem from continued operational efficiencies driven by the "Fit4Growth" program and the inherent scalability of its business model. This optimistic outlook, however, comes with a prudent caveat: it assumes no further significant slowdown in global economic activity, acknowledging the broader macroeconomic uncertainties that could impact consumer spending and market conditions.
A critical element of Amplifon’s future trajectory is the proposed acquisition and subsequent integration of GN Hearing. Amplifon initially announced this landmark planned acquisition in March 2026, signaling a major consolidation in the global hearing care market. This strategic move is not merely an expansion but a transformative step designed to catapult Amplifon into a new league of global leadership, offering an unparalleled combination of retail expertise and innovative hearing technology.
The rationale behind the GN Hearing acquisition is multifaceted. It promises to significantly broaden Amplifon’s product portfolio, integrating GN Hearing’s advanced hearing aid technology with Amplifon’s extensive global retail network. This synergy is expected to drive innovation, allowing Amplifon to offer a wider array of cutting-edge solutions tailored to diverse customer needs. From a market perspective, the acquisition will enhance Amplifon’s global reach, particularly strengthening its presence in key markets where GN Hearing has a strong foothold. This increased scale is anticipated to generate substantial operational efficiencies, supply chain advantages, and improved purchasing power, ultimately leading to greater profitability and value creation for all stakeholders. The integration is also expected to foster technological advancements, combining the R&D capabilities of both entities to accelerate the development of next-generation hearing solutions, including advancements in connectivity, artificial intelligence, and personalized sound experiences.
Planning for this complex integration is reportedly progressing according to schedule, a testament to the meticulous preparation being undertaken by both companies. However, the transaction remains subject to several customary closing conditions. These include obtaining necessary regulatory approvals from various competition authorities around the world, which is a standard but often lengthy process for deals of this magnitude. Additionally, the completion of the process to formally separate GN Hearing from its parent company, GN Group, is a prerequisite for the acquisition to finalize. Until all these conditions are met and the transaction officially closes, Amplifon and GN Hearing will continue to operate as entirely separate and independent companies, maintaining their distinct competitive strategies and market operations. This period of pre-integration planning is crucial for ensuring a smooth transition and maximizing the synergistic benefits once the deal is finalized.
Broader Industry Context and Amplifon’s Strategic Position
The global hearing care market is a dynamic sector driven by several powerful demographic and technological trends. An aging global population is a primary catalyst, as the incidence of hearing loss increases significantly with age. Coupled with this, rising awareness about the importance of early intervention and the destigmatization of hearing aids are fueling demand. Technological advancements, including smaller, more powerful, and discreet devices, enhanced connectivity (e.g., Bluetooth capabilities), and smart features, are continuously improving user experience and expanding the appeal of hearing solutions. The shift towards personalized care, where solutions are meticulously tailored to individual needs and lifestyles, is also a key industry trend.
Amplifon, as the global leader in hearing care retail, is exceptionally well-positioned to capitalize on these trends. Its extensive network of over 9,300 points of sale across 25 countries and five continents provides unparalleled access to customers worldwide. The company’s commitment to delivering "exclusive, innovative and highly personalised products and services" directly aligns with the industry’s focus on individualized solutions. The "Fit4Growth" program, with its emphasis on operational efficiency and strategic investments in marketing and clinic operations, is designed to strengthen this competitive advantage further.
The acquisition of GN Hearing marks a pivotal moment for Amplifon and the industry as a whole. It signifies a move towards greater vertical integration, combining a leading retail network with a strong manufacturing and R&D capability. This could potentially reshape the competitive landscape, setting new benchmarks for innovation, customer service, and market reach. Competitors will undoubtedly be watching closely as Amplifon embarks on this ambitious integration, which could lead to further consolidation or strategic partnerships within the sector. The combined entity would possess significant scale, technological prowess, and market penetration, enabling it to drive future trends in hearing care and address the growing global need for effective hearing solutions.
In conclusion, Amplifon’s second-quarter 2026 performance underscores its resilience, strategic acumen, and operational excellence. The highest organic growth in two years and significant profitability improvements validate its "Fit4Growth" initiatives. Coupled with a confident full-year outlook and the transformative potential of the GN Hearing integration, Amplifon is poised not just for continued growth but for a fundamental reshaping of its market leadership and capabilities in the global hearing care industry. The company’s proactive approach to market challenges and its strategic investments in both efficiency and expansion illustrate a clear vision for sustained success in an evolving global landscape.
About Amplifon
Amplifon, the global leader in the hearing care retail market, empowers people to rediscover all the emotions of sound. Amplifon’s around 19,400 employees and partners worldwide strive every day to understand the unique needs of every customer, delivering exclusive, innovative and highly personalised products and services to offer everyone the very best solution and an outstanding experience. With annual revenues of over €2 billion, the Group operates through a network of over 9,300 points of sale in 25 countries and five continents. For more information about the Group, please visit: https://corporate.amplifon.com.
Source: Amplifon
